Brochure
30 Jul 2025
Abzena's CDMO+ CRO Capabilities Overview
PDF 795 kB
Access our corporate brochure to discover how our robust toolkit of end-to-end capabilities can de-risk and streamline your bioconjugate or complex biologic from early R&D through commercial.
Content provided by our supplier
Abzena
-
Country/Region:United States
-
On CPHI since:2018
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
Other Content from Abzena (1)
-
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development.